Key result
Hypercholesterolemia amplified oxidant stress elicited by ischemia/reperfusion in rat mesenteric venules, which was attenuated by treatment with oxypurinol or superoxide dismutase.
Why the study?
Does treatment with oxypurinol or superoxide dismutase reduce oxidant stress and microvascular dysfunction in hypercholesterolemic rats exposed to ischemia/reperfusion?
Does treatment with oxypurinol or superoxide dismutase reduce oxidant stress and microvascular dysfunction in hypercholesterolemic rats exposed to ischemia/reperfusion?
Hypercholesterolemia exacerbates ischemia/reperfusion-induced microvascular dysfunction via enhanced oxidant production, which can be attenuated by antioxidant treatments.
Answers are grounded in this paper and cite their sources.
Animal data suggest antioxidants may blunt hypercholesterolemia-amplified oxidant stress in ischemia/reperfusion; leaves open human translation.
It has been shown that hypercholesterolemia (HCh) exaggerates the microvascular dysfunction that is elicited by ischemia and reperfusion (I/R). The objective of this study was to determine whether oxidants contribute to the exaggerated inflammatory responses and enhanced albumin leakage observed in HCh rat mesenteric venules exposed to I/R (10 minutes of ischemia and 30 minutes of reperfusion). Intravital videomicroscopy was used to quantify the number of adherent and emigrated leukocytes, albumin extravasation, platelet-leukocyte aggregation in postcapillary venules, and the degranulation of adjacent mast cells. Oxidation of the fluorochrome dihydrorhodamine 123 (DHR) was used to monitor oxidant production by venular endothelium. I/R was shown to elicit an increased DHR oxidation in venules of both control and HCh rats, with the latter group exhibiting a significantly larger response. Treatment with either oxypurinol or superoxide dismutase largely prevented the leukocyte recruitment, platelet-leukocyte aggregation, mast cell degranulation, and enhanced DHR oxidation elicited by I/R in HCh rats. The enhanced albumin leakage was reduced by superoxide dismutase but not by oxypurinol. These results indicate that HCh amplifies the oxidant stress elicited by I/R and that interventions that blunt the oxidant stress effectively attenuate the leukocyte, platelet, and mast cell activation that result from I/R.
No takes yet. Share an insight, caveat, or question.
Kurose et al. (1998) studied Hypercholesterolemia and ischemia/reperfusion injury. Oxypurinol or superoxide dismutase vs. Untreated hypercholesterolemic rats was evaluated on Oxidant production (DHR oxidation) and microvascular dysfunction. Hypercholesterolemia amplified oxidant stress elicited by ischemia/reperfusion in rat mesenteric venules, which was attenuated by treatment with oxypurinol or superoxide dismutase.
Synapse has enriched 10 related papers. Consider them for comparative context: